NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH

Journal of Molecular Neuroscience

Volumn 61, Issue 3, 2017, Pages 385-395

  Yao, Sheng Tao ^a   Cao, Fang ^a   Chen, Jia Lin ^a   Chen, Wei ^a   Fan, Rui Ming ^a   Li, Gang ^a   Zeng, You Chao ^a   Jiao, Song ^a   Xia, Xiang Ping ^a   Han, Chong ^a   Ran, Qi Shan ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Complement, NLRP3 inflammasome; IL 1 ; Intracerebral hemorrhage; Neuroinflammation

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; NLRP3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN TISSUE; BRAIN WATER; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RABBIT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; IMMUNOLOGY; METABOLISM; NEUROGENIC INFLAMMATION;

ANIMALS; BRAIN; CASPASE 1; CEREBRAL HEMORRHAGE; COMPLEMENT C3A; COMPLEMENT C5A; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROGENIC INFLAMMATION; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 85001740503     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-016-0874-9     Document Type: Article

References (59)

1. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69. doi:10.1038/nrn2038
2. Bonnardeaux A, Pichette V (2003) Complement dysregulation in haemolytic uraemic syndrome. Lancet 362:1514–1515. doi:10.1016/S0140-6736(03)14777-0
3. Chen GY, Nunez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826–837. doi:10.1038/nri2873
4. Couto Alves A et al (2013) Dysregulation of complement system and CD4+ T cell activation pathways implicated in allergic response. PLoS One 8:e74821. doi:10.1371/journal.pone.0074821
5. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550. doi:10.1146/annurev.immunol.021908.132612
6. Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720–3732. doi:10.1182/blood-2010-07-273417
7. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677. doi:10.1126/science.1156995
8. Doyle SL et al (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 18:791–798. doi:10.1038/nm.2717
9. Duewell P et al (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357–1361. doi:10.1038/nature08938
10. Fang C, Zhang X, Miwa T, Song WC (2009) Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114:1005–1015. doi:10.1182/blood-2009-01-198283
11. Fann DY et al (2013) Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis 4:e790. doi:10.1038/cddis.2013.326
12. Flower O, Smith M (2011) The acute management of intracerebral hemorrhage. Curr Opin Crit Care 17:106–114. doi:10.1097/MCC.0b013e328342f823
13. Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ (2007) System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. The Journal of neuroscience: the official journal of the Society for Neuroscience 27:10094–10105. doi:10.1523/JNEUROSCI.2459-07.2007
14. Forte A, Cipollaro M, Cascino A, Galderisi U (2005) Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases. Curr Drug Targets 6:21–29
15. Fountaine TM, Wood MJ, Wade-Martins R (2005) Delivering RNA interference to the mammalian brain. Current gene therapy 5:399–410
16. Fure H, Nielsen EW, Hack CE, Mollnes TE (1997) A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s. Scand J Immunol 46:553–557
17. Garrett MC et al (2009) Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage. Brain Res 1298:171–177. doi:10.1016/j.brainres.2009.04.047
18. Goldmann T, Tay TL, Prinz M (2013) Love and death: microglia, NLRP3 and the Alzheimer’s brain. Cell Res 23:595–596. doi:10.1038/cr.2013.24
19. Goldstein JN, Gilson AJ (2011) Critical care management of acute intracerebral hemorrhage. Curr Treat Options Neurol 13:204–216. doi:10.1007/s11940-010-0109-2
20. Halle A et al (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857–865. doi:10.1038/ni.1636
21. Hanamsagar R, Hanke ML, Kielian T (2012) Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol 33:333–342. doi:10.1016/j.it.2012.03.001
22. Heeringa SF, Cohen CD (2012) Kidney diseases caused by complement dysregulation: acquired, inherited, and still more to come. Clinical & developmental immunology 2012:695131. doi:10.1155/2012/695131
23. Hoegen T et al (2011) The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187:5440–5451. doi:10.4049/jimmunol.1100790
24. Hwang BY et al (2011) Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis 31:211–222. doi:10.1159/000321870
25. Jiang Y, Ma J, Li H, Liu Y, You C (2015) Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage. Lipids Health Dis 14:48. doi:10.1186/s12944-015-0047-9
26. Laudisi F et al (2013) Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release. J Immunol 191:1006–1010. doi:10.4049/jimmunol.1300489
27. Li G et al (2013) Neuroprotective effects of Argatroban and C5a receptor antagonist (PMX53) following intracerebral hemorrhage. Clin Exp Immunol. doi:10.1111/cei.12220
28. Lin S et al (2012) Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 9:46. doi:10.1186/1742-2094-9-46
29. Lint TF, Behrends CL, Baker PJ, Gewurz H (1976) Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes. J Immunol 117:1440–1446
30. Lok J et al (2012) Neuregulin-1 effects on endothelial and blood-brain-barrier permeability after experimental injury. Translational stroke research 3(Suppl 1):S119–S124. doi:10.1007/s12975-012-0157-x
31. Lu A, Tang Y, Ran R, Ardizzone TL, Wagner KR, Sharp FR (2006) Brain genomics of intracerebral hemorrhage. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 26:230–252. doi:10.1038/sj.jcbfm.9600183
32. Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7:31–40. doi:10.1038/nri1997
33. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. doi:10.1038/nature04516
34. Masada T, Hua Y, Xi G, Yang GY, Hoff JT, Keep RF (2001) Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J Neurosurg 95:680–686. doi:10.3171/jns.2001.95.4.0680
35. Mollnes TE et al (2002) Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100:1869–1877
36. Nakamura T, Xi G, Hua Y, Schallert T, Hoff JT, Keep RF (2004) Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 24:487–494. doi:10.1097/00004647-200405000-00002
37. Petrilli V, Dostert C, Muruve DA, Tschopp J (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19:615–622. doi:10.1016/j.coi.2007.09.002
38. Qureshi AI, Mendelow AD, Hanley DF (2009) Intracerebral haemorrhage. Lancet 373:1632–1644. doi:10.1016/S0140-6736(09)60371-8
39. Rathinam VA, Vanaja SK, Fitzgerald KA (2012) Regulation of inflammasome signaling. Nat Immunol 13:333–342. doi:10.1038/ni.2237
40. Ribo M, Grotta JC (2006) Latest advances in intracerebral hemorrhage. Current neurology and neuroscience reports 6:17–22
41. Rynkowski MA et al (2009) C3a receptor antagonist attenuates brain injury after intracerebral hemorrhage. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 29:98–107. doi:10.1038/jcbfm.2008.95
42. Samstad EO et al (2014) Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol 192:2837–2845. doi:10.4049/jimmunol.1302484
43. Sansing LH, Kaznatcheeva EA, Perkins CJ, Komaroff E, Gutman FB, Newman GC (2003) Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment. J Neurosurg 98:985–992. doi:10.3171/jns.2003.98.5.0985
44. Savage CD, Lopez-Castejon G, Denes A, Brough D (2012) NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol 3:288. doi:10.3389/fimmu.2012.00288
45. Srinivasan D, Yen JH, Joseph DJ, Friedman W (2004) Cell type-specific interleukin-1beta signaling in the CNS. The Journal of neuroscience: the official journal of the Society for Neuroscience 24:6482–6488. doi:10.1523/JNEUROSCI.5712-03.2004
46. Stahel PF et al (2000) Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice. J Neuroimmunol 109:164–172
47. Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481:278–286. doi:10.1038/nature10759
48. Stutz A, Golenbock DT, Latz E (2009) Inflammasomes: too big to miss. J Clin Invest 119:3502–3511. doi:10.1172/JCI40599
49. Sukumari-Ramesh S, Alleyne CH Jr (2016) Post-injury administration of tert-butylhydroquinone attenuates acute neurological injury after intracerebral hemorrhage in mice. Journal of molecular neuroscience: MN 58:525–531. doi:10.1007/s12031-016-0722-y
50. Suresh R, Chandrasekaran P, Sutterwala FS, Mosser DM (2016) Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation. J Cell Sci 129:1928–1939. doi:10.1242/jcs.179291
51. Sutterwala FS, Haasken S, Cassel SL (2014) Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci 1319:82–95. doi:10.1111/nyas.12458
52. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ (2010) Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9:167–176. doi:10.1016/S1474-4422(09)70340-0
53. Wei P, You C, Jin H, Chen H, Lin B (2014) Correlation between serum IL-1beta levels and cerebral edema extent in a hypertensive intracerebral hemorrhage rat model. Neurol Res 36:170–175. doi:10.1179/1743132813Y.0000000292
54. Wu B, Ma Q, Khatibi N, Chen W, Sozen T, Cheng O, Tang J (2010) Ac-YVAD-CMK decreases blood-brain barrier degradation by inhibiting caspase-1 activation of interleukin-1beta in intracerebral hemorrhage mouse model. Translational stroke research 1:57–64. doi:10.1007/s12975-009-0002-z
55. Xi G, Keep RF, Hoff JT (2002) Pathophysiology of brain edema formation. Neurosurg Clin N Am 13:371–383
56. Yang S et al (2006) The role of complement C3 in intracerebral hemorrhage-induced brain injury. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 26:1490–1495. doi:10.1038/sj.jcbfm.9600305
57. Yang F et al (2014) NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. doi:10.1038/jcbfm.2013.242
58. Yuen CM, Chiu CA, Chang LT, Liou CW, Lu CH, Youssef AA, Yip HK (2007) Level and value of interleukin-18 after acute ischemic stroke. Circulation journal: official journal of the Japanese Circulation Society 71:1691–1696
59. Zhang X et al (2007) Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110:228–236. doi:10.1182/blood-2006-12-063636